Search clinical trials for: ropinirole

Total 85 results

Bristol-Myers Squibb

Recruiting

A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-1)

Systemic Lupus Erythematosus

United States, Brazil, China, Germany, Italy, France, Mexico, Poland, Puerto Rico, Argentina, Canada, Colombia, Hong Kong, Peru, Romania, Portugal, Korea, Republic of, Turkey, Ireland, India, Lithuania, Bulgaria, Slovakia
Singapore General Hospital
Translational Immunology Institute

Recruiting

Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis

Plaque Psoriasis

Singapore
Singapore General Hospital
Translational Immunology Institute

Not yet recruiting

Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis

Plaque Psoriasis

Singapore
Beth Israel Deaconess Medical Center

Recruiting

Gait Analysis in Neurological Disease

Parkinson's Disease | Parkinsonian Disorders | Multiple System Atrophy | Corticobasal Degeneration | Progressive Supranuclear Palsy | Huntington Disease | Atypical Parkinson Disease | Gait, Frontal

United States
Bristol-Myers Squibb

Active, not recruiting

A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)

Lupus Erythematosus, Discoid | Lupus Erythematosus, Subacute Cutaneous

Mexico, Argentina, Australia, United States, France, Germany, Poland, Taiwan
MDD US Operations, LLC a subsidiary of Supernus...

Active, not recruiting

Infusion of Apomorphine: Long-term Safety Study (INFUS-ON)

Idiopathic Parkinson's Disease

United States
Massachusetts General Hospital

Withdrawn

Butrans for Treatment of Restless Legs Syndrome (Butrans)

Restless Legs Syndrome

United States
Myovant Sciences GmbH

Completed

SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain

Endometriosis

United States, Spain, Argentina, Belgium, Bulgaria, Canada, Czechia, Finland, Hungary, Poland, Portugal, South Africa, Ukraine, Australia, Brazil, Chile, Italy, New Zealand, Romania, Georgia
Titan Pharmaceuticals

Terminated

Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole

Parkinson Disease

United States
Vanderbilt University Medical Center

Completed

Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis

Cirrhosis | Muscle Cramp

United States
Population Health Research Institute

Completed

DIalysis Symptom COntrol-Restless Legs Syndrome Trial (DISCO-RLS)

Restless Legs Syndrome | End Stage Renal Disease

Canada
University of Alberta

Terminated

Effectiveness of Ropinirole and Gabapentin for the Treatment of RLS in Patients on Maintenance HD

Restless Legs Syndrome | End Stage Renal Disease

Canada
Children's Hospital of Philadelphia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...

Completed

Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease (Holiday)

Crohn Disease

United States
Columbia University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole

Prolactinoma | Hyperprolactinemia

United States
Baxter Healthcare Corporation

Completed

Efficacy and Safety of TISSEEL Lyo Compared to Manual Compression as an Adjunct to Haemostasis

Adjunct to Hemostasis During Vascular Surgery

Russian Federation
GlaxoSmithKline

Completed

Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)

Restless Legs Syndrome | Restless Legs Syndrome (RLS)

United States
GlaxoSmithKline

Completed

Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)

Parkinson Disease

Japan
GlaxoSmithKline

Completed

Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome

Restless Legs Syndrome

Japan
GlaxoSmithKline

Completed

Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528

Parkinson Disease

China
GlaxoSmithKline

Terminated

Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration)

Restless Legs Syndrome

Japan
GlaxoSmithKline

Completed

A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa

Parkinson Disease

China
GlaxoSmithKline

Terminated

A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients.

Parkinson Disease

Japan
GlaxoSmithKline

Completed

A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease (TANDEM-569)

Parkinson Disease

United States, Korea, Republic of, Estonia, Russian Federation, Slovakia, Argentina, Chile
GlaxoSmithKline

Completed

A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease (TANDEM-662)

Parkinson Disease

United States, Estonia, Korea, Republic of, Russian Federation, Slovakia
GlaxoSmithKline

Completed

A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and Aranda

Parkinson Disease

Belgium
GlaxoSmithKline

Completed

Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects

Parkinson Disease

China
The University of Texas Health Science Center,...

Completed

Cognitive Remediation for Cocaine Dependence

Cocaine Dependence

United States
Roxane Laboratories

Completed

A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted Conditions

Parkinson's Disease | Restless Leg Syndrome
Roxane Laboratories

Completed

A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions

Parkinson's Disease | Restless Leg Syndrome
GlaxoSmithKline

Completed

Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food

Restless Legs Syndrome

Germany, South Africa
GlaxoSmithKline

Completed

REQUIP RLS Post Marketing Surveillance (REQUIP RLS PMS)

Restless Legs Syndrome
GlaxoSmithKline

Completed

Ropinirole Tablets In Young Patients With Restless Legs Syndrome

Restless Legs Syndrome

United States, Belgium, France
GlaxoSmithKline

Completed

A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's

Parkinson Disease

Spain, France, Bulgaria, United Kingdom, Germany, Hungary, Russian Federation, South Africa, Italy, Canada, Czechia, Poland, Romania, Ukraine
National Institute of Neurological Disorders and...

Completed

Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome

Restless Legs Syndrome

United States
Cambridge Health Alliance
GlaxoSmithKline; Emory University

Completed

Ropinirole in the Treatment of Bipolar Depression

Bipolar Disorder

United States
GlaxoSmithKline

Completed

An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease

Parkinson's Disease | Parkinson Disease

United States, Spain, Poland, France, Belgium, Hungary, United Kingdom, Italy, Czech Republic
GlaxoSmithKline

Completed

Long-term Study Of Ropinirole In Restless Legs Syndrome

Restless Legs Syndrome

Denmark, Portugal, Switzerland, Australia, Italy, Spain, Czech Republic, Germany, Sweden, Slovakia, Norway
GlaxoSmithKline

Completed

Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa

Parkinson Disease

United States, France, Spain, Poland, Belgium, Hungary, Germany, Italy, Czech Republic
GlaxoSmithKline

Completed

Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease

Parkinson Disease

Japan
GlaxoSmithKline

Completed

Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's

Parkinson's Disease | Parkinson Disease | Dyskinesias

United States
University of California, Irvine
GlaxoSmithKline

Completed

Trial of Ropinirole in Motor Recovery After Stroke

Hemiparesis | Cerebrovascular Accident

United States
GlaxoSmithKline

Completed

Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome

Restless Legs Syndrome

United States, Canada
GlaxoSmithKline

Completed

12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome ((CR-RLS))

Restless Legs Syndrome | Restless Legs Syndrome (RLS)

United States
GlaxoSmithKline

Completed

Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole

Parkinson Disease

Germany, South Africa
GlaxoSmithKline

Completed

A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole

Restless Legs Syndrome

United States, United Kingdom
GlaxoSmithKline

Completed

RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole

Restless Legs Syndrome | Restless Legs Syndrome (RLS)

Spain, United States, Belgium, Sweden, Australia, Netherlands, United Kingdom, Italy, Austria, Germany, Denmark, France, Norway
GlaxoSmithKline

Completed

A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome

Restless Legs Syndrome | Restless Legs Syndrome (RLS)

United States
GlaxoSmithKline

Completed

Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome

Restless Legs Syndrome

United States, Canada
GlaxoSmithKline

Completed

A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)

Restless Legs Syndrome

United States
GlaxoSmithKline

Completed

Fibromyalgia Study In Adults

Fibromyalgia Syndrome, Primary

Italy, Belgium, Finland, Germany, Netherlands, United Kingdom, France, Denmark, Sweden

Search clinical trials for: ropinirole

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations